The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effects of cediranib (VEGF signaling inhibitor) on edema in newly diagnosed glioblastoma patients during initial chemoradiation.
Pavlina Polaskova
No relevant relationships to disclose
Marco C Pinho
No relevant relationships to disclose
Jayashree Kalpathy-Cramer
No relevant relationships to disclose
Alexander R Guimaraes
No relevant relationships to disclose
Patrick Y. Wen
Consultant or Advisory Role - AstraZeneca
A. Gregory Sorensen
Employment or Leadership Position - Siemens Healthcare Diagnostics
Consultant or Advisory Role - AstraZeneca
Research Funding - AstraZeneca
Rakesh K. Jain
Research Funding - MedImmune; Roche
Tracy Batchelor
Research Funding - AstraZeneca
Elizabeth Robins Gerstner
Research Funding - Merck